Amy Reichelt, Ph.D
Chief Innovation Officer
A recognized leader in neuroscience and neuropharmacology, specializing in psychedelic clinical development, neurodegeneration, and nutritional neurobiology, Dr. Reichelt has 15 years of expertise in translational medicine spanning from molecules to mind.
Dr. Reichelt received her PhD from Cardiff University, and has held academic appointments at globally renowned universities in Australia, Canada and UK. Dr. Reichelt has authored over 50 articles in top-tier scientific journals, spoken on international stages including Microdose Wonderland and TEDxSydney, and appeared as a scientific expert in TV productions including ABC’s The Science of Drugs.